Innovative ETF Strategies That Are Paying Off This Summer

Summary

Exchange-traded fund (ETF) inflows reached an astonishing $1 trillion for the first half of 2026 alone, the latest sign that investors everywhere are continuing to lean heavily on these vehicles to simplify their experience and add built-in diversification to their portfolios. Unsurprisingly, the number of funds available continues to skyrocket, although many investors stick with major ETFs tracking the S&P or other prominent indexes instead of venturing into unique strategies. There's certainly nothing wrong with a low-cost S&P 500 fund, but distinctive strategies have the potential to achieve strong returns with a niche basket of stocks. Although this approach to ETF investing may carry some additional risks as a more speculative play, it nonetheless has paid off for a few funds in particular. The ETFs below, with innovative approaches to biotech clinical trials, buy-now-pay-later programs, and disruptive medicine, respectively, may be worth watching. Distributing the Biotech Risk Across an Entire PortfolioThe Virtus LifeSci Biotech Clinical Trials ETF NYSEARCA: BBC is a fund holding approximately 132 positions in biotechnology stocks with clinical trials ongoing. These companies range from drug manufacturers to novel therapeutics firms and from small start-ups to major producers, although most of the fund is made up of small-cap names or smaller. Virtus LifeSci Biotech Clinical Trials ETF TodayBBCVirtus LifeSci Biotech Clinical Trials ETF$50.65 +0.98 (+1.97%) As of 09:48 AM Eastern52-Week Range$20.87▼$54.95Dividend Yield1.28%Assets Under Management$47.16 million Clinical stage biotechs are a highly speculative industry overall—companies pin most or all of their success on the potential of a small number of drug trials in a race against time as they burn through money, most often in a pre-profitability state. Of course, for companies that do see success in their trials, the potential for outsized rewards is tremendous. A fund like BBC takes that risk and spreads i...